By The Numbers
Envision Healthcare Corp. filed its quarter two lobbying disclosure on July 29, reporting $251,093 in expenses, a modest increase from the $227,080 the company reported in quarter one of 2026. Gaby Fowler, director of state and federal policy, was the registered in-house lobbyist for the quarter.
Envision also worked with outside firms McDermottPlus LLC and Liberty Partners Group LLC, which each filed separate disclosures for the quarter, reporting $30,000 and $10,000, respectively. Across all registrants, Envision's federal lobbying expenditures have totaled an estimated $1,635,173 over the past four quarters.
Broader Context
Bipartisan legislation addressing No Surprises Act enforcement has been introduced in both chambers. According to the American Medical Association, the No Surprises Act Enforcement Act would address widespread noncompliance by health plans with the law's payment requirements, particularly after physicians win payment disputes. Health Affairs reports that more than half of all provider-initiated disputes in the first half of 2025 were filed against just three insurers: UnitedHealthcare, Blue Cross Blue Shield of Texas, and Aetna.
Envision is also tracking Medicare reimbursement pressures. The American Hospital Association said it was disappointed that the Centers for Medicare & Medicaid Services finalized the proposed efficiency adjustment and changes to the practice expense methodology, which disadvantage certain providers, including hospital-based physicians. The company is simultaneously lobbying on the Patients First Act, which, according to Rep. Kim Schrier's (D-WA) office, would reform the Medicare physician fee schedule and improve seniors' access by strengthening independent practice incentives.
On the Medicaid front, Envision is monitoring fallout from the One Big Beautiful Bill Act, signed into law in July 2025, which implements work requirements and other coverage restrictions. The company is also addressing workforce challenges by encouraging continued processing of J-1 waivers for foreign-trained physicians, a backlog that has threatened placements in underserved areas.
The Bottom Line
Envision is running a multifront lobbying operation, pressing for insurer accountability under the No Surprises Act while defending physician reimbursement against Medicare payment cuts and Medicaid coverage restrictions. With enforcement legislation now pending in Congress and the 2026 physician fee schedule reshaping payments to hospital-based providers, the company's spending signals it expects these fights to intensify heading into next year.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article